vs

Side-by-side financial comparison of IMMUCELL CORP (ICCC) and Sound Financial Bancorp, Inc. (SFBC). Click either name above to swap in a different company.

Sound Financial Bancorp, Inc. is the larger business by last-quarter revenue ($9.5M vs $5.5M, roughly 1.7× IMMUCELL CORP). On growth, Sound Financial Bancorp, Inc. posted the faster year-over-year revenue change (1.5% vs -8.4%). Sound Financial Bancorp, Inc. produced more free cash flow last quarter ($7.0M vs $-1.8M). Over the past eight quarters, Sound Financial Bancorp, Inc.'s revenue compounded faster (5.5% CAGR vs 3.9%).

ImmuCell Corp is a US-based animal health biotechnology company that develops, manufactures and markets innovative products for livestock, primarily dairy cattle. Its core offerings include preventive and therapeutic solutions for common bovine health issues such as mastitis, serving agricultural producers and veterinary providers across North America.

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

ICCC vs SFBC — Head-to-Head

Bigger by revenue
SFBC
SFBC
1.7× larger
SFBC
$9.5M
$5.5M
ICCC
Growing faster (revenue YoY)
SFBC
SFBC
+9.9% gap
SFBC
1.5%
-8.4%
ICCC
More free cash flow
SFBC
SFBC
$8.8M more FCF
SFBC
$7.0M
$-1.8M
ICCC
Faster 2-yr revenue CAGR
SFBC
SFBC
Annualised
SFBC
5.5%
3.9%
ICCC

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ICCC
ICCC
SFBC
SFBC
Revenue
$5.5M
$9.5M
Net Profit
$-139.7K
Gross Margin
42.9%
Operating Margin
0.4%
27.1%
Net Margin
-2.5%
Revenue YoY
-8.4%
1.5%
Net Profit YoY
80.1%
EPS (diluted)
$-0.02
$0.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICCC
ICCC
SFBC
SFBC
Q4 25
$9.5M
Q3 25
$5.5M
$9.8M
Q2 25
$6.4M
$10.4M
Q1 25
$8.1M
$9.2M
Q4 24
$7.8M
$9.4M
Q3 24
$6.0M
$9.1M
Q2 24
$5.5M
$8.6M
Q1 24
$7.3M
$8.6M
Net Profit
ICCC
ICCC
SFBC
SFBC
Q4 25
Q3 25
$-139.7K
$1.7M
Q2 25
$501.9K
$2.1M
Q1 25
$1.4M
$1.2M
Q4 24
Q3 24
$-701.7K
$1.2M
Q2 24
$-1.5M
$795.0K
Q1 24
$-437.9K
$770.0K
Gross Margin
ICCC
ICCC
SFBC
SFBC
Q4 25
Q3 25
42.9%
Q2 25
43.7%
Q1 25
41.6%
Q4 24
36.5%
Q3 24
26.3%
Q2 24
22.5%
Q1 24
31.6%
Operating Margin
ICCC
ICCC
SFBC
SFBC
Q4 25
27.1%
Q3 25
0.4%
21.3%
Q2 25
8.8%
24.5%
Q1 25
13.9%
15.9%
Q4 24
8.0%
24.6%
Q3 24
-9.6%
15.6%
Q2 24
-25.3%
11.4%
Q1 24
-4.1%
10.9%
Net Margin
ICCC
ICCC
SFBC
SFBC
Q4 25
Q3 25
-2.5%
17.3%
Q2 25
7.8%
19.8%
Q1 25
17.9%
12.7%
Q4 24
Q3 24
-11.7%
12.7%
Q2 24
-28.0%
9.2%
Q1 24
-6.0%
9.0%
EPS (diluted)
ICCC
ICCC
SFBC
SFBC
Q4 25
$0.87
Q3 25
$-0.02
$0.66
Q2 25
$0.06
$0.79
Q1 25
$0.16
$0.45
Q4 24
$0.09
$0.74
Q3 24
$-0.09
$0.45
Q2 24
$-0.20
$0.31
Q1 24
$-0.06
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICCC
ICCC
SFBC
SFBC
Cash + ST InvestmentsLiquidity on hand
$3.9M
$138.5M
Total DebtLower is stronger
$9.5M
Stockholders' EquityBook value
$29.8M
$109.4M
Total Assets
$45.7M
$1.1B
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICCC
ICCC
SFBC
SFBC
Q4 25
$138.5M
Q3 25
$3.9M
$101.2M
Q2 25
$102.5M
Q1 25
$131.5M
Q4 24
$3.8M
$43.6M
Q3 24
$148.9M
Q2 24
$1.3M
$135.1M
Q1 24
$960.3K
$138.0M
Total Debt
ICCC
ICCC
SFBC
SFBC
Q4 25
Q3 25
$9.5M
Q2 25
Q1 25
$8.7M
Q4 24
$9.0M
Q3 24
$9.4M
Q2 24
$9.8M
Q1 24
$10.2M
Stockholders' Equity
ICCC
ICCC
SFBC
SFBC
Q4 25
$109.4M
Q3 25
$29.8M
$107.5M
Q2 25
$29.9M
$106.0M
Q1 25
$29.0M
$104.4M
Q4 24
$27.5M
$103.7M
Q3 24
$26.4M
$102.2M
Q2 24
$23.5M
$101.3M
Q1 24
$24.6M
$101.0M
Total Assets
ICCC
ICCC
SFBC
SFBC
Q4 25
$1.1B
Q3 25
$45.7M
$1.1B
Q2 25
$46.7M
$1.1B
Q1 25
$45.6M
$1.1B
Q4 24
$45.1M
$993.6M
Q3 24
$44.4M
$1.1B
Q2 24
$41.9M
$1.1B
Q1 24
$43.1M
$1.1B
Debt / Equity
ICCC
ICCC
SFBC
SFBC
Q4 25
Q3 25
0.32×
Q2 25
Q1 25
0.30×
Q4 24
0.33×
Q3 24
0.36×
Q2 24
0.42×
Q1 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICCC
ICCC
SFBC
SFBC
Operating Cash FlowLast quarter
$-1.2M
$7.2M
Free Cash FlowOCF − Capex
$-1.8M
$7.0M
FCF MarginFCF / Revenue
-32.3%
73.4%
Capex IntensityCapex / Revenue
10.8%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$715.4K
$12.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICCC
ICCC
SFBC
SFBC
Q4 25
$7.2M
Q3 25
$-1.2M
$3.8M
Q2 25
$1.6M
$-494.0K
Q1 25
$1.6M
$1.9M
Q4 24
$-3.1K
$2.9M
Q3 24
$-639.3K
$3.3M
Q2 24
$581.8K
$-4.0M
Q1 24
$418.5K
$3.5M
Free Cash Flow
ICCC
ICCC
SFBC
SFBC
Q4 25
$7.0M
Q3 25
$-1.8M
$3.8M
Q2 25
$1.4M
$-518.0K
Q1 25
$1.2M
$1.8M
Q4 24
$-199.3K
$2.9M
Q3 24
$-727.7K
$3.2M
Q2 24
$471.0K
$-5.6M
Q1 24
$348.1K
$1.9M
FCF Margin
ICCC
ICCC
SFBC
SFBC
Q4 25
73.4%
Q3 25
-32.3%
38.3%
Q2 25
22.4%
-5.0%
Q1 25
15.4%
19.8%
Q4 24
-2.6%
30.4%
Q3 24
-12.1%
35.5%
Q2 24
8.6%
-65.4%
Q1 24
4.8%
22.2%
Capex Intensity
ICCC
ICCC
SFBC
SFBC
Q4 25
1.8%
Q3 25
10.8%
0.4%
Q2 25
2.4%
0.2%
Q1 25
4.1%
0.4%
Q4 24
2.5%
0.8%
Q3 24
1.5%
0.5%
Q2 24
2.0%
18.7%
Q1 24
1.0%
19.0%
Cash Conversion
ICCC
ICCC
SFBC
SFBC
Q4 25
Q3 25
2.24×
Q2 25
3.19×
-0.24×
Q1 25
1.09×
1.59×
Q4 24
Q3 24
2.84×
Q2 24
-5.05×
Q1 24
4.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons